| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Hackman Jeffrey S. is a Chief Executive Officer at FENNEC PHARMACEUTICALS INC.. Recent SEC Form 4 filings include 2 buys and 0 sells.
Estimated insider holdings value: $102K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 19, 2025 | FENC Fennec Pharmaceuticals Inc. | Chief Executive Officer | Buy | 15,000 | $6.97 | $104,601.60 | +1,449% | +7.2% | - |